San Donato Hospital
| Italien | Türkei | Österreich | |
| Tomotherapie | von $32,000 | von $12,000 | von $30,000 |
| Stereotaktische Radiochirurgie | von $25,000 | von $4,500 | von $17,000 |
| Protonenstrahltherapie | von $70,000 | von $70,000 | von $80,000 |
| Kraniotomie | von $25,000 | von $5,650 | von $20,000 |
| Gamma-Messer | von $30,000 | von $6,300 | von $32,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Hirntumor-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Hirntumor einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Hirntumor-Behandlungsreise nie allein.
Professor Pietro Mortini ist auf minimalinvasive Hirnchirurgie spezialisiert – präzisere Eingriffe und kürzere Erholungszeiten am San Raffaele Scientific Institute.
Italian neurosurgical centers utilize diverse intraoperative technologies like neuronavigation and neuromapping to enhance tumor removal precision. Leading specialists use real-time functional mapping during awake craniotomies to preserve speech and movement. Advanced visualization tools like 5-ALA fluorescence-guided surgery help doctors distinguish malignant cells from healthy tissue.
Bookimed Expert Insight: Italian neurosurgery excels at combining diagnostic hybrid imaging with surgical practice. Professor Dr. Pietro Mortini at San Raffaele utilizes patented tissue regeneration methods and advanced neuromapping. This level of technical integration is why clinics like Maria Cecilia Hospital earn specialized neurosurgery accreditations. These centers often serve as international research hubs for complex cranial base surgeries.
Patient Consensus: Patients emphasize that intraoperative MRI and ultrasound provide immense peace of mind. They frequently note how awake craniotomy techniques helped them maintain vital speech and motor skills.
Italian oncologists use molecular profiling to map specific genomic alterations within brain tumors. This process identifies targets for immunotherapy or personalized treatments. Specialists use these genetic insights to select clinical trials or off-label drugs when standard brain cancer therapies fail to work.
Bookimed Expert Insight: Italian neurosurgery centers like Maria Cecilia Hospital integrate molecular insights with hybrid imaging technologies. Our data shows these facilities often handle complex cases where profiling results directly influence the choice between traditional resection and advanced radiosurgery. This multidisciplinary approach ensures that genetic data and surgical planning are coordinated for better individual outcomes.
Patient Consensus: Patients note that molecular profiling helps refine a diagnosis even if a specific drug is not found. They emphasize bringing full pathology reports to every consultation to ensure the medical team can compare genetic findings with imaging results.
Italy features top-rated neuro-oncology centers like Istituto Neurologico Carlo Besta and Ospedale San Raffaele in Milan. These facilities hold IRCCS accreditation, combining elite clinical care with advanced research. Leading surgeons use technologies like Gamma Knife and intraoperative MRI to treat complex brain tumors with precision.
Bookimed Expert Insight: Milan serves as a critical hub because its top clinics share IRCCS status. This means patients benefit from research-grade molecular testing not available in general hospitals. For example, San Raffaele performs over 52,000 surgeries yearly, providing a volume of experience that often leads to better outcomes in complex glioma resections.
Patient Consensus: Patients emphasize finding a surgeon who specializes exclusively in brain tumors rather than general neurosurgery. Many recommend traveling to Milan or Rome specifically for a multidisciplinary tumor board review.
Italy provides advanced high-precision radiation options including Gamma Knife and CyberKnife for inoperable tumors. Academic centers in Milan and Pavia specialize in stereotactic radiosurgery and hadrontherapy. These non-surgical technologies target complex lesions while sparing healthy brain tissue in sensitive or deep areas.
Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital and San Donato combine research with clinical practice through IRCCS status. This often grants patients earlier access to hybrid protocols. While Gamma Knife costs approximately $30,000 to $50,000, choosing a specialized radiosurgery package can reduce costs to around $14,500.
Patient Consensus: Patients note it is important to request a multidisciplinary tumor board review. They emphasize bringing detailed MRI scans to confirm if a tumor qualifies for single-session radiosurgery.
Evaluating an Italian neurosurgeon requires verifying their FNOMCeO registry status and Specializzazione in Neurochirurgia. Prioritize surgeons at IRCCS research hospitals like San Raffaele in Milan. Ensure they utilize neuronavigation and neuromapping for complex brain cancer resections to protect vital motor functions.
Bookimed Expert Insight: Italian neurosurgery excels when specialized centers like San Raffaele also focus on experimental biological tissue regeneration. Dr. Pietro Mortini even holds patents for tissue regeneration devices while performing unique fetal neurosurgeries. For patients, this means choosing a director-level surgeon who leads both a clinical department and a research unit often grants access to more surgical options.
Patient Consensus: Patients emphasize finding a surgeon who explains MRI results in plain language rather than using complex medical jargon. They note that the best specialists are those willing to discuss the need for second opinions and the importance of a multidisciplinary tumor board review.